enVVeno Medical (NVNO) Profit After Tax (2017 - 2026)

enVVeno Medical has reported Profit After Tax for 10 years, with the latest figure at -$3.6 million in Q2 2026.

• On a quarterly basis, Profit After Tax rose 46.22% year-over-year to -$3.6 million in Q2 2026; TTM through Jun 2026 was -$15.7 million, a 31.84% increase from a year earlier, with the FY2025 full-year figure at -$19.5 million, up 10.76% from the prior year.
• Profit After Tax was -$3.6 million for Q2 2026 at enVVeno Medical, up from -$3.8 million in the prior quarter.
• The five-year high for Profit After Tax was -$3.6 million in Q2 2026, with the low at -$7.1 million in Q2 2022.
• Average Profit After Tax over 5 years is -$5.4 million, with a median of -$5.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Profit After Tax plunged 196.97% in 2022, then jumped 46.22% in 2026.
• Over 5 years, Profit After Tax stood at -$6.2 million in 2022, then grew by 8.59% to -$5.6 million in 2023, then decreased by 10.27% to -$6.2 million in 2024, then jumped by 40.02% to -$3.7 million in 2025, then grew by 3.64% to -$3.6 million in 2026.
• The last three Profit After Tax figures came in at -$3.6 million (Q2 2026), -$3.8 million (Q1 2026), and -$3.7 million (Q4 2025), per Business Quant data.